Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of ProAlgaZyme Novel Algae Infusion vs. Placebo on Metabolic Syndrome and Markers of Cardiovascular Health

NCT00489333 is registered in ClinicalTrials.gov with Health Enhancement Products, Inc. as lead sponsor.

NCT NCT00489333
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00489333 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of ProAlgaZyme Novel Algae Infusion vs. Placebo on Metabolic Syndrome and Markers of Cardiovascular Health
Lead sponsor
Health Enhancement Products, Inc.
Phase
Not applicable
Overall status
Completed
Start date
May 31, 2006
Completion date
September 30, 2006
Enrollment
52 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome x